MicroCME modules are 15 to 30 minute courses that will offer CME designed to fit busy schedules.
- Biomarker Interpretations and How This Would Aid in Treatment Choice and Prognosis Prediction
- Kids Are Not Little Adults: Unique Aspects to Diagnosis and Treatment of Cough in Children
- Emerging Therapies for Refractory Urticaria
- Dermatitis in Skin of Color
- Do Patients Receiving Subcutaneous Immunotherapy Need To Have an Epinephrine Auto-injector Prescribed?
- SCIT or SLIT: No One Option Is Perfect - A Role for Shared Decision-making
- Beyond OIT: How Biologics Can Help Patients With Food Allergy
- Navigating Current Asthma Choices
- Coding Update
- Practice Parameter - Rhinitis
- Practice Parameter - Anaphylaxis
- Practice Parameter - Diagnostic Testing for Peanut Allergy
- The Changing Paradigm of Telemedicine
- Evaluating a Patient With Elevated Peripheral Eosinophilia
- The Impact of the Microbiome on Atopic Dermatitis
- Alterations in the Microbiome in Patients With Food Allergies
- FDA-Approved Oral Immunotherapy
- Ongoing Avoidance Without Treatment
- Using Shared Decision-making to Guide Patients Through the Options
- FPIES - Prevalence, Diagnosis and Management Pearls
- Eosinophilic Esophagitis
- Evaluation and Management of Adverse Reactions to Vaccines
- Causes, Contributing Factors and Evaluation of the Patient
- Today's Surgical Options and Outcomes
- Treatment and Management of Infant Anaphylaxis
By participating in these podcasts, learners should be able to:
- Provide physicians with the latest research in the field of allergy/immunology relevant to practice.
- Provide physicians with tools and techniques to implement the latest therapy recommendations.
- Provide physicians with the tools they need to monitor their practice and assess the implementation of therapy recommendations.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.